New chagas pill tested in small safety study
NCT ID NCT05523596
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 30 times
Summary
This early-phase study tested an oral drug called ICM20 in 13 adults with Chagas disease. The main goal was to check for side effects and see how many people stayed on the drug for 28 and 60 days. The study was not designed to cure the disease, but to gather safety information for future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SAFETY ISSUES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Baylor College of Medicine
Houston, Texas, 77030, United States
-
Culmore Clinic
Falls Church, Virginia, 22044, United States
-
Parkway Medical
Glen Burnie, Maryland, 21061, United States
Conditions
Explore the condition pages connected to this study.